Okayama, Japan

Hidenori Yamada


Average Co-Inventor Count = 3.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2007-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hidenori Yamada: Innovator in Protein and Peptide Technologies

Introduction

Hidenori Yamada is a prominent inventor based in Okayama, Japan. He has made significant contributions to the field of protein and peptide technologies, holding a total of 3 patents. His work focuses on developing novel compounds and methods that enhance the stability and efficacy of pharmaceutical proteins.

Latest Patents

Yamada's latest patents include a thiosulfonate compound and a reversible cationization agent for proteins and peptides. The objective of this invention is to provide a compound that can reversibly cationize a wider range of proteins and peptides with high stability and accuracy. This innovation is particularly useful for high degrees of purification and recovery. Additionally, he has developed a method for solubilizing proteins and peptides using this agent. Another notable patent involves a method for transducing pharmaceutical proteins or polypeptides into cells by forming a conjugate with a cationic polymer. This method allows for the efficient delivery of fluorescently labeled proteins into cells.

Career Highlights

Hidenori Yamada has worked with notable organizations such as Nippon Shokubai Co., Ltd. and Okayama University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Yamada has collaborated with esteemed colleagues, including Junichiro Futami and Hidetaka Nakanishi. These partnerships have further enriched his research endeavors and innovations.

Conclusion

Hidenori Yamada's work in the field of protein and peptide technologies showcases his dedication to advancing scientific knowledge and improving pharmaceutical applications. His innovative patents reflect his commitment to enhancing the stability and efficacy of therapeutic proteins.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…